Blonder Tongue Laboratories, Inc. (BDRL)

BDRL Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018
Net Income	-2.92	0.08	-7.47	-0.74	-1.34
Depreciation & Amortization	0.89	1.14	1.1	1.11	0.52
Share-Based Compensation	0.55	0.73	0.4	0.71	0.49
Other Operating Activities	0.1	-3.12	2.76	-7.61	0.91
Operating Cash Flow	-1.38	-1.17	-3.21	-6.54	0.59
Capital Expenditures	-0.05	-0.03	-0.17	9.53	-0.08
Other Investing Activities	-0.01	-0.06	-0.03	-0.05	-0.02
Investing Cash Flow	-0.06	-0.09	-0.19	9.47	-0.1
Share Issuance / Repurchase	0	0.56	0.83	0.01	0.04
Debt Issued / Paid	1.24	0.89	2.08	-2.93	-0.14
Financing Cash Flow	1.24	1.46	2.9	-2.92	-0.1
Net Cash Flow	-0.2	0.21	-0.5	0.01	0.39
Free Cash Flow	-1.43	-1.2	-3.38	2.99	0.51
Free Cash Flow Growth	-	-	-	490.71%	-
Free Cash Flow Margin	-7.89%	-7.60%	-20.62%	15.06%	2.33%
Free Cash Flow Per Share	-0.11	-0.10	-0.34	0.31	0.06

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).